Samsung Medical Center-Lymphoma Cohort Study-II
Conditions: official terms
Conditions: Keywords
Lymphoma, Prognosis, Biomarker, Quality of life
Study Type
Observational [Patient Registry]
Study Phase
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
The purpose of this study is to establish a model which can predict the treatment outcome and the risk of treatment-related morbidity in patients with lymphoma.
Detailed Description
Although the cure rate of lymphoma has been increased due to the development of newer effective drugs, a substantial portion of patients is still suffered from relapse. Furthermore, the treatment-related morbidity is another factor which can make the treatment outcome worse in patients with lymphoma, especially elderly patients. Thus, this study is going to assess factors which may affect the treatment outcome and the risk of treatment-related morbidity.

1.Biologic factors associated with the aggressiveness of lymphoma

- molecular markers in serum, cytogenetic markers 2.Factors associated with the risk of treatment-related morbidity

- comorbidity, nutrition status, performance status, quality of life at diagnosis
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 19 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients who were diagnosed as lymphoma

- Over 19 years old

- Patients who agreed the enrollment of study

- Informed consent for sampling

Exclusion Criteria:

•Patients who do not want to join the study
Samsung Medical Center
Seoul, Korea, Republic of
Status: Recruiting
Contact: Won Seog Kim, MD, PhD - 82-2-3410-6548 -
Start Date
January 2012
Completion Date
December 2014
Samsung Medical Center
Samsung Medical Center
Record processing date processed this data on July 28, 2015 page